INTERNATIONAL PATENT: EVAXION BIOTECH A/S, EXPRES2ION BIOTECHNOLOGIES APS FILES APPLICATION FOR "IMMUNOGENIC VARIANTS OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B"

GENEVA, March 24 -- EVAXION BIOTECH A/S (Dr Neergaards Vej 5f2970 Horsholm), EXPRES2ION BIOTECHNOLOGIES APS (Agern Alle 12970 Horsholm) filed a patent application (PCT/EP2024/075475) for "IMMUNOGENIC VARIANTS OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B" on Sep 12, 2024. With publication no. WO/2025/056665, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SORENSEN, Anders Bundgard (c/o Evaxion Biotech A/SDr. Neergaards Vej 5f2970 Horsholm), THUESEN, Nikolas (c/o Evaxion Biotech A/SDr. Neergaards Vej 5f2970 Horsholm), DOROSZ, Je...